WO2011048554A3 - Association d'un lysat de probiotique et d'un derive c-glycoside - Google Patents
Association d'un lysat de probiotique et d'un derive c-glycoside Download PDFInfo
- Publication number
- WO2011048554A3 WO2011048554A3 PCT/IB2010/054744 IB2010054744W WO2011048554A3 WO 2011048554 A3 WO2011048554 A3 WO 2011048554A3 IB 2010054744 W IB2010054744 W IB 2010054744W WO 2011048554 A3 WO2011048554 A3 WO 2011048554A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- combination
- glycoside derivative
- lysate
- probiotic lysate
- probiotic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
Abstract
La présente invention concerne l'utilisation cosmétique d'une association comprenant un lysat d'au moins un microorganisme probiotique du genre Bifidobacterium sp. avec au moins un dérivé C-glycoside à titre d'actif utile pour le soin cosmétique des matières kératiniques.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0957374 | 2009-10-21 | ||
FR0957374A FR2951377B1 (fr) | 2009-10-21 | 2009-10-21 | Association d'un lysat de probiotique et d'un derive c-glycoside |
US27278809P | 2009-11-03 | 2009-11-03 | |
US61/272,788 | 2009-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011048554A2 WO2011048554A2 (fr) | 2011-04-28 |
WO2011048554A3 true WO2011048554A3 (fr) | 2011-06-23 |
Family
ID=42244536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2010/054744 WO2011048554A2 (fr) | 2009-10-21 | 2010-10-20 | Association d'un lysat de probiotique et d'un derive c-glycoside |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2951377B1 (fr) |
WO (1) | WO2011048554A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104144693A (zh) * | 2012-01-16 | 2014-11-12 | E·麦肯纳 | 用于治疗肝脏疾病和障碍的组合物和方法 |
US20150374607A1 (en) | 2012-02-14 | 2015-12-31 | The Procter & Gamble Company | Topical use of a skin-commensal prebiotic agent and compositions containing the same |
JP2015535829A (ja) | 2012-09-21 | 2015-12-17 | マッケーナ、エリザベス | 天然に存在するCpGオリゴヌクレオチド組成物およびその治療的適用 |
CA3018865A1 (fr) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Composition nettoyante stimulant les peptides antimicrobiens |
US10874700B2 (en) | 2016-03-31 | 2020-12-29 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
EP3544575A1 (fr) | 2016-11-23 | 2019-10-02 | GOJO Industries, Inc. | Composition désinfectante comprenant une substance active probiotique/prébiotique |
FR3097441B1 (fr) * | 2019-06-24 | 2021-06-25 | Oreal | Composition cosmétique comprenant un lysat deBifidobacterium species, un extrait de levure du genreSaccharomyces, et un monosaccharide mannose et ses utilisations cosmétiques |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464362A (en) * | 1980-06-27 | 1984-08-07 | Estee Lauder Inc. | Topical skin repair composition |
WO2002028402A1 (fr) * | 2000-10-06 | 2002-04-11 | Société des Produits Nestlé S.A. | Utilisation de bacteries lactiques probiotiques afin d'equilibrer le systeme immunitaire de la peau |
FR2886297A1 (fr) * | 2005-05-30 | 2006-12-01 | Oreal | Composes c-glycosides et leur utilisation pur depigmenter la peau |
FR2899588A1 (fr) * | 2006-04-07 | 2007-10-12 | Oreal | Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee |
WO2007116012A1 (fr) * | 2006-04-07 | 2007-10-18 | L'oréal | Utilisation d'un composé c-glycoside dérivé du l-fucose et du d-fucose en tant qu'agent pour activer et réguler l'immunité cutanée |
EP2033627A2 (fr) * | 2007-09-04 | 2009-03-11 | L'oreal | Utilisation d'un lysat de Bifidobacterium species pour le traitement de peaux sensibles |
WO2009053564A2 (fr) * | 2007-09-04 | 2009-04-30 | L'oreal | Utilisation cosmetique de lysat de bifidobacterium species pour renforcer la fonction barriere cutanee |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5658880A (en) | 1993-06-16 | 1997-08-19 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
US5508387A (en) | 1993-08-04 | 1996-04-16 | Glycomed Incorporated | Selectin binding glycopeptides |
US5614615A (en) | 1995-03-21 | 1997-03-25 | The Scripps Research Institute | Sialyl Lewis X mimetics incorporating fucopeptides |
FR2818547B1 (fr) | 2000-12-22 | 2006-11-17 | Oreal | Nouveaux derives c-glycosides et utilisation |
WO2003105769A2 (fr) | 2002-06-13 | 2003-12-24 | New York University | C-glycolipide de synthese et utilisation de celui-ci pour le traitement du cancer, des maladies infectieuses et des maladies auto-immunes |
-
2009
- 2009-10-21 FR FR0957374A patent/FR2951377B1/fr active Active
-
2010
- 2010-10-20 WO PCT/IB2010/054744 patent/WO2011048554A2/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464362A (en) * | 1980-06-27 | 1984-08-07 | Estee Lauder Inc. | Topical skin repair composition |
WO2002028402A1 (fr) * | 2000-10-06 | 2002-04-11 | Société des Produits Nestlé S.A. | Utilisation de bacteries lactiques probiotiques afin d'equilibrer le systeme immunitaire de la peau |
FR2886297A1 (fr) * | 2005-05-30 | 2006-12-01 | Oreal | Composes c-glycosides et leur utilisation pur depigmenter la peau |
FR2899588A1 (fr) * | 2006-04-07 | 2007-10-12 | Oreal | Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee |
WO2007116012A1 (fr) * | 2006-04-07 | 2007-10-18 | L'oréal | Utilisation d'un composé c-glycoside dérivé du l-fucose et du d-fucose en tant qu'agent pour activer et réguler l'immunité cutanée |
EP2033627A2 (fr) * | 2007-09-04 | 2009-03-11 | L'oreal | Utilisation d'un lysat de Bifidobacterium species pour le traitement de peaux sensibles |
WO2009053564A2 (fr) * | 2007-09-04 | 2009-04-30 | L'oreal | Utilisation cosmetique de lysat de bifidobacterium species pour renforcer la fonction barriere cutanee |
Non-Patent Citations (1)
Title |
---|
CAVEZZA A ET AL: "Synthesis of Pro-Xylane<TM>: A new biologically active C-glycoside in aqueous media", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 19, no. 3, 1 February 2009 (2009-02-01), pages 845 - 849, XP025925835, ISSN: 0960-894X, [retrieved on 20081213], DOI: DOI:10.1016/J.BMCL.2008.12.037 * |
Also Published As
Publication number | Publication date |
---|---|
FR2951377A1 (fr) | 2011-04-22 |
WO2011048554A2 (fr) | 2011-04-28 |
FR2951377B1 (fr) | 2012-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011048554A3 (fr) | Association d'un lysat de probiotique et d'un derive c-glycoside | |
EP2168570A3 (fr) | Extraits d'isochrysis sp. | |
BR112012013722A2 (pt) | uso cosmético de pelo menos um microorganismo probiótico, especialmente do gênero lactobacillus sp.e processo cosmético. | |
CL2012000869A1 (es) | Composicion que comprende cepa seleccionada de lactobacillus plantarum cect 7527, o cepas mutantes de la misma; uso de una composicion para prevenir y/o tratar transtornos cardiovasculares. | |
WO2010000877A3 (fr) | Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations | |
WO2011073437A3 (fr) | Compositions cosmétiques ou dermatologiques à base de bactériocines et de prébiotiques | |
WO2014018596A3 (fr) | Alpha (1,2) fucosyltransférases appropriées pour une utilisation dans la production d'oligosaccharides fucosylés | |
WO2012030984A3 (fr) | Compositions pour la peau et leurs applications | |
IN2012DN01638A (fr) | ||
MX2010003258A (es) | Utilizacion de un nuevo agente natural en composiciones cosmeticas. | |
TN2012000611A1 (en) | Formulations of rifaximin and uses thereof | |
WO2009031106A3 (fr) | Utilisation d'une combinaison d'hespéridine et d'un micro-organisme pour influer sur la fonction de barrière de la peau | |
WO2011093833A3 (fr) | Formulations effervescentes contenant de la céphalosporine de deuxième génération | |
WO2008085221A3 (fr) | Utilisation thérapeutique de cellules exprimant cd31 | |
PL2364712T3 (pl) | Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie | |
MX2010000422A (es) | Combinacion cosmetica de un microorganismo y de un derivado de fitosfigosina. | |
BR112012013720A2 (pt) | uso cosmético de pelo menos um microorganismo probiótico, especialmente do gênero lactobacillus sp.e processo cosmético. | |
TW200942530A (en) | Pyridine compounds | |
WO2009093104A3 (fr) | Utilisation d'huile d'olive transestérifiée dans le domaine cosmétique | |
WO2010147830A3 (fr) | Modulateurs aminothiazole de bêta-3-adrénorécepteur | |
WO2009019294A3 (fr) | Bromhydrate de bupropion et applications thérapeutiques | |
WO2011042902A3 (fr) | Microcapsules comprenant du peroxyde de benzoyle et compositions topiques comprenant celles-ci | |
WO2010046061A3 (fr) | Préparations cosmétiques et/ou pharmaceutiques | |
GEP201606589B (en) | Novel bacterium and extracts of said bacterium and the use of same in dermatology | |
AU2012345659A8 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10776170 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10776170 Country of ref document: EP Kind code of ref document: A2 |